SOURCE: Milestone Scientific, Inc.

January 19, 2016 11:40 ET

Wand Dental, Inc. Announces New Distribution Arrangements With Henry Schein, Inc.

LIVINGSTON, NJ--(Marketwired - January 19, 2016) - Wand Dental Inc., a wholly-owned subsidiary of Milestone Scientific, Inc. (NYSE MKT: MLSS), announced today that it has received an initial stocking order from Henry Schein, Inc. for The Wand® STA® Computer Assisted Anesthesia System. The stocking order enables Henry Schein, the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, to complete customer purchase requests for The Wand System and related disposable hand-pieces from its dental customers in the U.S. and Canada, beginning 2016.

To help educate its customers about the benefits of The Wand, Henry Schein is training specific members of its sales team to become experts in the features and benefits of the System. Henry Schein will also continue to distribute the disposables for Wand Dental, Inc.'s legacy anesthesia system, The Compudent®.

The Wand STA is the first and market-leading computer-controlled local anesthesia system, with over 50 million injections performed worldwide. The Wand® performs both traditional and newer dental anesthesia injections in a more effective and comfortable way for both the patient and the provider. The instrument utilizes patented technologies like computer-regulated flow rates, Dynamic Pressure Sensing (DPS®), and a uniquely ergonomic hand-piece to enable significant improvements over the traditional dental syringe, which has remained virtually unchanged for over 160 years.

Gian Domenico Trombetta, CEO of Wand Dental, Inc. commented, "This arrangement expands on an already long and productive relationship with Henry Schein. It will enable us to leverage our patented injection technologies with Henry Schein's field representatives and their unparalleled access, relationships, and marketing platforms in the professional dental segment in the U.S. and Canada. We are excited to work closely with Henry Schein to expand the market for The Wand STA as we believe there is large opportunity in the domestic U.S. & Canadian markets for growth."

About Wand Dental, Inc.

Headquartered in Livingston, NJ, Wand Dental, Inc. is a wholly-owned subsidiary of Milestone Scientific, Inc. and is engaged in the manufacture and sales of advanced computer-controlled drug delivery technologies to the global dental market. The company currently sells its award-winning products through a global distribution network serving North and South America, Asia, Africa, Europe and the Middle East.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Wand Dental Inc.'s ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Wand Dental's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Wand Dental Inc.'s periodic filings with the Securities and Exchange Commission. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Wand Dental Inc. undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact Information

  • Contact:
    David Waldman or Klea Theoharis
    Crescendo Communications, LLC
    Email: mlss@crescendo-ir.com
    Tel: 212-671-1020